Division of Allergy Pulmonary and Critical Care Medicine
-
April 6, 2023
System repairs donor lungs for transplantation
A Vanderbilt team has discovered that donor lungs rejected for transplant can be repaired using cross-circulation with a xenogeneic host. -
March 9, 2023
Study finds RSV may evade vaccines via rapid mutation
A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading. -
March 6, 2023
Cell-free hemoglobin in pulmonary hypertension
Cell-free hemoglobin generated by the lungs may be a therapeutic target for treating pulmonary arterial hypertension, Vanderbilt researchers found. -
February 23, 2023
Bastarache takes on new role for research career development
Julie Bastarache, MD, has been appointed Assistant Vice President for Clinical & Translational Scientist Development at Vanderbilt University Medical Center. -
February 21, 2023
Diabetes drug may improve asthma
New biomarker finding strengthens the case for using GLP-1R agonists to treat patients with Type 2 diabetes who also suffer from asthma. -
February 16, 2023
Penicillin allergy test recommended for pregnant women
Vanderbilt experts say getting rid of unnecessary penicillin allergy labels allows women to receive better treatments for common infections during pregnancy and delivery. -
February 2, 2023
Study of two sepsis interventions finds identical outcomes
Vanderbilt University Medical Center had a leading role in a large national study designed to compare two early interventions in the treatment of patients with sepsis, the body’s severe response to an uncontrolled infection.